There could be an upside to incorporating AI for the FDA. Using AI to assist in final drug reviews would "represent a chance ...

The U.S. Food and Drug Administration said on Thursday all its centers will deploy artificial intelligence internally ...

OpenAI has reportedly met with officials from the Food and Drug Administration to discuss how AI could speed up drug ...

OpenAI and the U.S. Food and Drug Administration have been meeting to discuss the health regulator's use of AI, technology ...

The unintentional theme of today’s issue is the struggle for control over how we implement AI in the U.S. On one side, where ...

Read about the move to scale use of AI across all FDA centers by the end of June and learn more about future plans to expand ...

The FDA has started exploring how AI can be used to accelerate drug approvals in collaboration with OpenAI amid oversight ...

The Food and Drug Administration on Thursday announced an aggressive agency-wide Artificial intelligence adoption timeline ...

The FDA  plans to launch generative AI across all of its centers by June 30. The agency has also appointed its first chief AI ...

Food and Drug Administration Director Martin Makary announced the agency-wide deployment of an artificial intelligence tool ...

The FDA has appointed its first chief artificial intelligence officer, with an eye on supporting the agency’s internal IT ...

Commissioner Martin Makary also said the agency would roll out a generative AI system across its centers that will help FDA ...